WMIF MAIN SITE

2025 Event Site

Michael Mihm, PhD

Michael Mihm, PhD is currently an Asset Lead, Oncology Development at Astellas Pharma.

Asset Lead, Astellas Pharma

Cancer’s Newest Treatments | Early Detection, Early Treatment, Rapid Therapeutic Development
Speakers Agenda

Subscribe

Join our email list to recieve exclusive offers

Opt In

© 2025 Mass General Brigham Incorporated. All Rights Reserved